Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL15361722 | 0.97 | NOS1 (0.32) | NOS1 | |
| Hydrochloric Acid SCHEMBL15361564 | 0.97 | NOS1 (0.32) | NOS1 | |
| Bromide SCHEMBL384831 | 0.97 | NOS1 (0.32) | NOS1 | |
| SCHEMBL3632269 | 0.87 | — | — | |
| SCHEMBL7572162 | 0.83 | — | — | |
| SCHEMBL7572165 | 0.83 | — | — | |
| SCHEMBL3050049 | 0.79 | HSD17B10 (0.33) | — | |
| Trifluoromethanesulfonic Acid SCHEMBL1137934 | 0.78 | HSD17B10 (0.32) | — | |
| SCHEMBL4578379 | 0.76 | — | — | |
| SCHEMBL22582101 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 375 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4470972-A1 | PROCESS FOR PRODUCING ONIUM SALTS OF BIS(FLUOROSULFONYL)IMIDE | SPECIALTY OPERATIONS FRANCE (FR) | 2024-12-04 | — | — | EP | claimed |
| US-20190248721-A1 | PROCESSES FOR PREPARING CALIXARENES | SI GROUP, INC. | 2019-08-15 | — | — | US | claimed |
| EP-1984438-B2 | ANTISTATIC POLYURETHANE | BASF SE (DE) | 2016-05-18 | — | — | EP | claimed |
| US-20150057388-A1 | ANTISTATIC POLYURETHANE | BASF SE (DE) | 2015-02-26 | — | — | US | claimed |
| EP-1812382-B1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF SE (DE) | 2013-01-23 | — | — | EP | claimed |
| WO-2012036392-A3 | HUMAN ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR FAB ANTIBODY AND A PHARMACEUTICAL COMPOSITION FOR TREATING TUMOURS COMPRISING THE SAME | 주식회사 아이지세라피 (KR) | 2012-05-10 | — | — | WO | claimed |
| US-8116067-B2 | Nanoporous insulating oxide electrolyte membrane ultracapacitor, button cell, stacked cell and coiled cell and methods of manufacture and use thereof | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2012-02-14 | — | — | US | claimed |
| EP-1930376-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2011-12-07 | — | — | EP | claimed |
| US-8013080-B2 | Curable composition | KANEKA CORPORATION (JP) | 2011-09-06 | — | — | US | claimed |
| EP-1984438-B1 | ANTISTATIC POLYURETHANE | BASF SE (DE) | 2010-03-31 | — | — | EP | claimed |
| EP-1789160-B1 | METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE | BASF SE (DE) | 2009-11-18 | — | — | EP | claimed |
| US-20090154060-A1 | Nanoporous Insulating oxide Electrolyte Membrane Ultracapacitor, Button Cell, Stacked Cell and Coiled Cell and Methods of Manufacture and use Thereof | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2009-06-18 | — | — | US | claimed |
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESSELLSCHAFT (DE) | 2009-04-30 | — | — | US | claimed |
| EP-1984438-A1 | ANTISTATIC POLYURETHANE | BASF SE (DE) | 2008-10-29 | — | — | EP | claimed |
| US-20070293707-A1 | Method for Separating Hydrogen Chloride and Phosgene | BASF AKTIENGESELLSCHAFT (DE) | 2007-12-20 | — | — | US | claimed |
| WO-2007090755-A1 | ANTISTATIC POLYURETHANE | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-16 | — | — | WO | claimed |
| US-20070176148-A1 | Organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2007-08-02 | — | — | US | claimed |
| EP-1812382-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-01 | — | — | EP | claimed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | claimed |
| WO-2006048171-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-11 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | PGLS, INMT, PNMT | NOS1 1481/4885 |
| US-20190248721-A1 | PROCESSES FOR PREPARING CALIXARENES | CALU, CALD1, CALR | NOS1 1846/4885 |
| US-20070293707-A1 | Method for Separating Hydrogen Chloride and Phosgene | PSPH, SLC9B2, HVCN1 | NOS1 3664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.